The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of microsatellite ...
read more
Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced that the U.S. Food and Drug ...
read more
Vaxxinity, Inc. announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. Food and ...
read more
Belite Bio, Inc, a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, such as ...
read more
Bayer announced that the FDA has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor ...
read more
Fresenius Kabi has introduced Bortezomib for Injection, a new generic equivalent to Velcade® in the U.S. and the newest addition to the most ...
read more
Worldwide Clinical Trials, Inc. a midsize, full-service contract research organization (CRO), announced that Rosemarie Corrigan has joined the company...
read more
Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-...
read more
Eisai announced the appointment of Thomas D. Fagan Jr. as VP of US Alzheimer's Disease Commercial.
read more
Tuesday, October 11, 2022
Ginkgo Bioworks is collaborating with Merck to engineer up to four enzymes for use as biocatalysts in Merck's active pharmaceutical ingredient (API) ...
read more
Wednesday, October 12, 2022
Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining their strengths in AI genome ...
read more
Wednesday, October 12, 2022
Agilent Technologies announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom.
read more
Lannett Company announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture Numbrino®, the company's branded...
read more
Thursday, November 03, 2022
Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, ...
read more
Monday, November 14, 2022
Opiant Pharmaceuticals entered a merger agreement to be acquired by Indivior, a subsidiary of Indivior. Under the terms of the agreement, Indivior ...
read more